Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing by Jiang, Y, Southam, AD, Trova, S, Beke, F, Alhazmi, B, Francis, T, Radotra, A, di Maio, A, Drayson, MT, Bunce, CM, Khanim, FL

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients by Shah, V, Sherborne, AL, Johnson, DC, Ellis, S, Price, A, Chowdhury, F, Kendall, J, Jenner, MW, Drayson, MT, Owen, RG, Gregory, WM, Morgan, GJ, Davies, FE, Cook, G, Cairns, DA, Houlston, RS, Jackson, G, Kaiser, MF, NCRI Haematology Clinical Studies Group